Skip to main content

Animations

Fox Trial Finder Seeks 30,000 Registered Volunteers This Year

Fox Trial Finder Seeks 30,000 Registered Volunteers This Year

Fox Trial Finder Ambassador Hal Halvorsen and his wife, Mary

Officially launched in April 2012 to help increase the flow of willing volunteers into clinical trials that urgently need more people, Fox Trial Finder (foxtrialfinder.org) already has made inroads into the problem: 15,000 people with and without Parkinson’s disease have completed profiles to find the best trial matches and be alerted when new trials begin. In 2013, Fox Trial Finder is taking on the ambitious goal of attaining 30,000 registered volunteers.

The site is expanding into Europe while continuing to pursue new U.S.-based volunteers. “While 30,000 volunteers sounds impressive, even that number is merely a milestone on our path. Estimates hold that it would take at least 70,000 volunteers to fully populate every clinical trial under way in Parkinson’s today,” says Debi Brooks, co-founder and executive vice chairman of MJFF. “We continue working to educate our community about the urgent need for patient collaboration in research, and to provide tools that make it easier for patients and their loved ones to get involved.”

In early summer, foreign-language versions of the Fox Trial Finder site will begin to launch in France, Italy, Spain, Germany and Austria. The expansion will add more than 200 new Parkinson’s disease trials to the Fox Trial Finder database. MJFF is also focusing on increasing registered English-speaking volunteers in the United States, United Kingdom, Ireland, Australia and Canada.

New technology will support Fox Trial Finder’s growing numbers. A recent update makes it easier to keep track receive weekly email alerts when a new trial is recruiting in their area and needs participants who match their profile. Future updates will continue to improve the user experience for both volunteers and trial teams.

 

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.